Industry News
Bevacizumab Slows Progression Of Metastatic Breast Cancer But Has No Impact On Survival
Jul 12, 2012
The cancer drug bevacizumab (Avastin®) offers only a modest benefit in delaying disease progression in patients with advanced stage breast cancer, according to a systematic review by Cochrane researchers... Read More
For Anemia Prevention During Pregnancy, Iron Supplements Need Not Be Taken Every Day
Jul 12, 2012
Taking iron supplements one to three times a week instead of every day is just as effective at preventing anaemia in pregnant women, according to the findings of a new Cochrane systematic review. The authors of the review also showed that women experienced fewer side effects when taking iron supplements intermittently rather than daily... Read More
For Anemia Prevention During Pregnancy, Iron Supplements Need Not Be Taken Every Day
Jul 12, 2012
Taking iron supplements one to three times a week instead of every day is just as effective at preventing anaemia in pregnant women, according to the findings of a new Cochrane systematic review. The authors of the review also showed that women experienced fewer side effects when taking iron supplements intermittently rather than daily... Read More
Killing Cancer Cells With Weed Plant Anti-Cancer Drug
Jul 11, 2012
A new anticancer drug made from a weed-like plant that grows naturally in the Mediterranean region has been shown to effectively destroy cancer cells in mice, according to a study published in the journal Science Translational Medicine... Read More
Discovery Of Melanoma-Promoting Gene
Jul 11, 2012
Black skin cancer, also known as melanoma, is particularly aggressive and becoming increasingly common in Switzerland. Despite intensive research, however, there is still no treatment. Researchers from the University of Zurich have now discovered a gene that plays a central role in black skin cancer... Read More
Exploiting "Molecular Glues" To Target Disease Relevant Proteolytic Enzymes
Jul 11, 2012
Scientists at the University Medical Center of Johannes Gutenberg University Mainz in Germany identified a novel strategy to target the oncologically relevant protein-cleaving enzyme Taspase1. Taspase1 levels are not only elevated in cancer cells of patients with head and neck tumors and other solid malignancies but the enzyme is also critical for the development of leukemias... Read More
Specialized Ultrasound Used In Preclinical Studies To Detect Presence Of Cancer
Jul 11, 2012
From the air, the twists and turns of rivers can easily be seen. In the body, however, tracing the twists and turns of blood vessels is difficult, but important. Vessel "bendiness" can indicate the presence and progression of cancer. This principle led UNC scientists to a new method of using a high-resolution ultrasound to identify early tumors in preclinical studies... Read More
First Evidence For Targeting Of Pol I As New Approach To Cancer Therapy
Jul 11, 2012
Cylene Pharmaceuticals has announced that research collaborators at the Peter MacCallum Cancer Centre (Peter Mac) in Melbourne, Australia have established, for the first time, that RNA Polymerase I (Pol I) activity is essential for cancer cell survival and that its inhibition selectively activates p53 to kill tumors... Read More
Tumor Cells In Mice Destroyed By Drug From Mediterranean Weed
Jul 11, 2012
Scientists at the Johns Hopkins Kimmel Cancer Center, working with Danish researchers, have developed a novel anticancer drug designed to travel - undetected by normal cells - through the bloodstream until activated by specific cancer proteins... Read More
Comparison Of Cancer Screening Rates Between Those With And Without Rheumatoid Arthritis
Jul 11, 2012
New research reveals that rheumatoid arthritis (RA) patients do not receive fewer cancer screening tests than the general population... Read More
Previous Page Next Page